Alovudine (fluorothymidine) is an antiviral agent which was being developed by Medivir. It was discontinued after a Phase II trial in 2005 due to toxicity. It is a DNA polymerase inhibitor.
See also
Fluorothymidine F-18, an isotopically enriched version of alovudine used as a PET tracer